AMS issued Method Patent for Trans-Obturator Slings:Enforceable? Doubtful
Method patents are blatantly anti-competitive and as such may run afoul of the Federal Trade Commission (FTC). We would urge…
Advocating for meaningful real health reform
Method patents are blatantly anti-competitive and as such may run afoul of the Federal Trade Commission (FTC). We would urge…
There is no doubt that there is misguided spending by drug and device companies, particularly in the arena of marketing.…